中心性浆液性脉络膜视网膜病变的发病机制和治疗进展
Progress in the Pathogenesis and Treatment of Central Serous Chorioretinopathy
DOI: 10.12677/jcpm.2025.41069, PDF,   
作者: 高龙洋：南华大学衡阳医学院，湖南 衡阳；孙立新*, 李 玲*：中南大学湘雅医学院附属常德医院眼科，湖南 常德
关键词: 中心性浆液性脉络膜视网膜病变；微脉冲激光；药物；Central Serous Chorioretinopathy； Micropulse Laser； Drugs
摘要: 中心性浆液性脉络膜视网膜病变(CSC)是临床上常见的眼底疾病之一，好发于中青年男性，属于自限性疾病，主要表现为后极部视网膜类圆形视网膜神经上皮下积液。急性中心性浆液性脉络膜视网膜病变(aCSC)患者大多能自愈，视力恢复良好。而慢性中心性浆液性脉络膜视网膜病变(cCSC)患者预后较差，部分继发脉络膜新生血管。目前CSC的具体发病机制仍不明确。对于CSC的治疗也未达成共识，目前有光动力疗法、传统氩激光光凝、微脉冲激光以及药物等多种方法用于临床。本文主要综合分析中心性浆液性脉络膜视网膜病变的发病机制和治疗进展。
Abstract: Central serous chorioretinopathy (CSC) is one of the commom fundus diseases in clinical practice. CSC usually occurs in the young and middle-aged men. It is a self-limited disease, mainly manifested as round retinal subepithelial fluid accumulation in the posterior polar retina. Most patients with acute central serous chorioretinopathy (aCSC) can heal themselves and their visual acuity recovers well. However, patients with chronic central serous chorioretinopathy(cCSC) have a poor prognosis, and some of them have secondary choroidal neovascularization. At present, the specific pathogenesis of CSC is still unclear. There is no consensus on the treatment of csc. Currently, there are many clinical methods such as photodynamic therapy, traditional argon laser photocoagulation, micropulse laser and drugs. This article is comprehensive analysis of the pathogenesis and treatment progress of central serous chorioretinopathy.
文章引用：高龙洋, 孙立新, 李玲. 中心性浆液性脉络膜视网膜病变的发病机制和治疗进展[J]. 临床个性化医学, 2025, 4(1): 463-470. https://doi.org/10.12677/jcpm.2025.41069

参考文献

[1] Kaye, R., Chandra, S., Sheth, J., Boon, C.J.F., Sivaprasad, S. and Lotery, A. (2020) Central Serous Chorioretinopathy: An Update on Risk Factors, Pathophysiology and Imaging Modalities. Progress in Retinal and Eye Research, 79, Article ID: 100865. [Google Scholar] [CrossRef] [PubMed]
[2] Fung, A.T., Yang, Y. and Kam, A.W. (2023) Central Serous Chorioretinopathy: A Review. Clinical & Experimental Ophthalmology, 51, 243-270. [Google Scholar] [CrossRef] [PubMed]
[3] Arora, S., Sridharan, P., Arora, T., Chhabra, M. and Ghosh, B. (2019) Subthreshold Diode Micropulse Laser versus Observation in Acute Central Serous Chorioretinopathy. Clinical and Experimental Optometry, 102, 79-85. [Google Scholar] [CrossRef] [PubMed]
[4] Wong, K.H., Lau, K.P., Chhablani, J., Tao, Y., Li, Q. and Wong, I.Y. (2015) Central Serous Chorioretinopathy: What We Have Learnt So Far. Acta Ophthalmologica, 94, 321-325. [Google Scholar] [CrossRef] [PubMed]
[5] Scheider, A., Nasemann, J.E. and Lund, O.E. (1993) Fluorescein and Indocyanine Green Angiographies of Central Serous Choroidopathy by Scanning Laser Ophthalmoscopy. American Journal of Ophthalmology, 115, 50-56. [Google Scholar] [CrossRef] [PubMed]
[6] Spaide, R.F., Campeas, L., Haas, A., Yannuzzi, L.A., Fisher, Y.L., Guyer, D.R., et al. (1996) Central Serous Chorioretinopathy in Younger and Older Adults. Ophthalmology, 103, 2070-2080. [Google Scholar] [CrossRef] [PubMed]
[7] Iida, T., Kishi, S., Hagimura, N. and Shimizu, K. (1999) Persistent and Bilateral Choroidal Vascular Abnormalities in Central Serous Chorioretinopathy. Retina, 19, 508-512. [Google Scholar] [CrossRef] [PubMed]
[8] Boned-Murillo, A., Albertos-Arranz, H., Diaz-Barreda, M.D., Orduna-Hospital, E., Sánchez-Cano, A., Ferreras, A., et al. (2021) Optical Coherence Tomography Angiography in Diabetic Patients: A Systematic Review. Biomedicines, 10, Article 88. [Google Scholar] [CrossRef] [PubMed]
[9] Feucht, N., Maier, M., Lohmann, C.P. and Reznicek, L. (2016) OCT Angiography Findings in Acute Central Serous Chorioretinopathy. Ophthalmic Surgery, Lasers and Imaging Retina, 47, 322-327. [Google Scholar] [CrossRef] [PubMed]
[10] Giovannini, A., Scassellati-Sforzolini, B., Dʼaltobrando, E., Mariotti, C., Rutili, T. and Tittarelli, R. (1997) Choroidal Findings in the Course of Idiopathic Serous Pigment Epithelium Detachment Detected by Indocyanine Green Videoangiography. Retina, 17, 286-293. [Google Scholar] [CrossRef] 
[11] Piccolino, F.C., Borgia, L., Zinicola, E. and Zingirian, M. (1995) Indocyanine Green Angiographic Findings in Central Serous Chorioretinopathy. Eye, 9, 324-332. [Google Scholar] [CrossRef] [PubMed]
[12] Negi, A. and Marmor, M.F. (1984) Experimental Serous Retinal Detachment and Focal Pigment Epithelial Damage. Archives of Ophthalmology, 102, 445-449. [Google Scholar] [CrossRef] [PubMed]
[13] Zhou, F., Yao, J., Jiang, Q. and Yang, W. (2022) Efficacy of Navigated Laser Photocoagulation for Chronic Central Serous Chorioretinopathy: A Retrospective Observational Study. Disease Markers, 2022, Article ID: 7792291. [Google Scholar] [CrossRef] [PubMed]
[14] Spaide, R.F., Ledesma-Gil, G. and Gemmy Cheung, C.M. (2021) Intervortex Venous Anastomosis in Pachychoroid-Related Disorders. Retina, 41, 997-1004. [Google Scholar] [CrossRef] [PubMed]
[15] Hayreh, S.S. (1975) Segmental Nature of the Choroidal Vasculature. British Journal of Ophthalmology, 59, 631-648. [Google Scholar] [CrossRef] [PubMed]
[16] Matsumoto, H., Kishi, S., Mukai, R. and Akiyama, H. (2019) Remodeling of Macular Vortex Veins in Pachychoroid Neovasculopathy. Scientific Reports, 9, Article No. 14689. [Google Scholar] [CrossRef] [PubMed]
[17] Sonoda, S., Sakamoto, T., Yamashita, T., Shirasawa, M., Uchino, E., Terasaki, H., et al. (2014) Choroidal Structure in Normal Eyes and after Photodynamic Therapy Determined by Binarization of Optical Coherence Tomographic Images. Investigative Opthalmology & Visual Science, 55, 3893-3899. [Google Scholar] [CrossRef] [PubMed]
[18] Chung, Y., Kim, J.W., Kim, S.W. and Lee, K. (2016) Choroidal Thickness in Patients with Central Serous Chorioretinopathy: Assessment of Haller and Sattler Layers. Retina, 36, 1652-1657. [Google Scholar] [CrossRef] [PubMed]
[19] Hiroe, T. and Kishi, S. (2018) Dilatation of Asymmetric Vortex Vein in Central Serous Chorioretinopathy. Ophthalmology Retina, 2, 152-161. [Google Scholar] [CrossRef] [PubMed]
[20] Mantel, I., Schalenbourg, A. and Zografos, L. (2013) Evanescent Vaso-Occlusive Choroidal Pseudo-Tumor with Acute Painful Onset: A Presumed Vortex Vein Occlusion. Graefe’s Archive for Clinical and Experimental Ophthalmology, 252, 753-759. [Google Scholar] [CrossRef] [PubMed]
[21] González Martín-Moro, J., Sales-Sanz, M., Oblanca-Llamazares, N., Bustos-García, A., Méndez-Cendón, J.C. and Fandiño, E. (2018) Choroidal Thickening in a Case of Carotid Cavernous Fistula. Orbit, 37, 306-308. [Google Scholar] [CrossRef] [PubMed]
[22] Venkatesh, P., Chawla, R., Tripathy, K., Singh, H.I. and Bypareddy, R. (2016) Scleral Resection in Chronic Central Serous Chorioretinopathy Complicated by Exudative Retinal Detachment. Eye and Vision, 3, Article No. 23. [Google Scholar] [CrossRef] [PubMed]
[23] Bouzas, E.A., Karadimas, P. and Pournaras, C.J. (2002) Central Serous Chorioretinopathy and Glucocorticoids. Survey of Ophthalmology, 47, 431-448. [Google Scholar] [CrossRef] [PubMed]
[24] Farman, N. and Rafestin-Oblin, M. (2001) Multiple Aspects of Mineralocorticoid Selectivity. American Journal of Physiology-Renal Physiology, 280, F181-F192. [Google Scholar] [CrossRef] [PubMed]
[25] Haimovici, R., Koh, S., Gagnon, D.R., Lehrfeld, T. and Wellik, S. (2004) Risk Factors for Central Serous Chorioretinopathy. Ophthalmology, 111, 244-249. [Google Scholar] [CrossRef] [PubMed]
[26] Zhao, M., Célérier, I., Bousquet, E., Jeanny, J., Jonet, L., Savoldelli, M., et al. (2012) Mineralocorticoid Receptor Is Involved in Rat and Human Ocular Chorioretinopathy. Journal of Clinical Investigation, 122, 2672-2679. [Google Scholar] [CrossRef] [PubMed]
[27] Cat, A.N.D., Griol‐Charhbili, V., Loufrani, L., Labat, C., Benjamin, L., Farman, N., et al. (2010) The Endothelial Mineralocorticoid Receptor Regulates Vasoconstrictor Tone and Blood Pressure. The FASEB Journal, 24, 2454-2463. [Google Scholar] [CrossRef] [PubMed]
[28] Khairallah, M., Kahloun, R. and Tugal-Tutkun, I. (2012) Central Serous Chorioretinopathy, Corticosteroids, and Uveitis. Ocular Immunology and Inflammation, 20, 76-85. [Google Scholar] [CrossRef] [PubMed]
[29] Behar-Cohen, F. and Zhao, M. (2016) Corticosteroids and the Retina: A Role for the Mineralocorticoid Receptor. Current Opinion in Neurology, 29, 49-54. [Google Scholar] [CrossRef] [PubMed]
[30] Ghadiali, Q., Jung, J.J., Yu, S., Patel, S.N. and Yannuzzi, L.A. (2016) Central Serous Chorioretinopathy Treated with Mineralocorticoid Antagonists. Retina, 36, 611-618. [Google Scholar] [CrossRef] [PubMed]
[31] Rahimy, E., Pitcher, J.D., Hsu, J., Adam, M.K., Shahlaee, A., Samara, W.A., et al. (2018) A Randomized Double-Blind Placebo-Control Pilot Study of Eplerenone for the Treatment of Central Serous Chorioretinopathy (ECSELSIOR). Retina, 38, 962-969. [Google Scholar] [CrossRef] [PubMed]
[32] Delyani, J.A. (2000) Mineralocorticoid Receptor Antagonists: The Evolution of Utility and Pharmacology. Kidney International, 57, 1408-1411. [Google Scholar] [CrossRef] [PubMed]
[33] Bousquet, E., Beydoun, T., Zhao, M., Hassan, L., Offret, O. and Behar-Cohen, F. (2013) Mineralocorticoid Receptor Antagonism in the Treatment of Chronic Central Serous Chorioretinopathy. Retina, 33, 2096-2102. [Google Scholar] [CrossRef] [PubMed]
[34] Pichi, F., Carrai, P., Ciardella, A., Behar-Cohen, F. and Nucci, P. (2016) Comparison of Two Mineralcorticosteroids Receptor Antagonists for the Treatment of Central Serous Chorioretinopathy. International Ophthalmology, 37, 1115-1125. [Google Scholar] [CrossRef] [PubMed]
[35] Nicolò, M., Ferro Desideri, L., Vagge, A. and Traverso, C.E. (2020) Current Pharmacological Treatment Options for Central Serous Chorioretinopathy: A Review. Pharmaceuticals, 13, Article 264. [Google Scholar] [CrossRef] [PubMed]
[36] Nielsen, J.S. and Jampol, L.M. (2011) Oral Mifepristone for Chronic Central Serous Chorioretinopathy. Retina, 31, 1928-1936. [Google Scholar] [CrossRef] [PubMed]
[37] Ratanasukon, M., Bhurayanontachai, P. and Jirarattanasopa, P. (2012) High-Dose Antioxidants for Central Serous Chorioretinopathy; the Randomized Placebo-Controlled Study. BMC Ophthalmology, 12, Article No. 20. [Google Scholar] [CrossRef] [PubMed]
[38] Malle, E.M., Posch-Pertl, L., Renner, W., Pinter-Hausberger, S., Singer, C., Haas, A., et al. (2018) Role of the Tissue-Type Plasminogen Activator −7351C > T and Plasminogen Activator Inhibitor 1 4G/5G Gene Polymorphisms in Central Serous Chorioretinopathy. Ophthalmic Genetics, 39, 714-716. [Google Scholar] [CrossRef] [PubMed]
[39] Caccavale, A. (2010) Low-Dose Aspirin as Treatment for Central Serous Chorioretinopathy. Clinical Ophthalmology, 4, 899-903. [Google Scholar] [CrossRef] [PubMed]
[40] Moreno-Morillo, F.J., Fernández-Vigo, J.I., Güemes-Villahoz, N., Burgos-Blasco, B., López-Guajardo, L. and Donate-López, J. (2021) Update on the Management of Chronic Central Serous Chorioretinopathy. Archivos de la Sociedad Española de Oftalmología (English Edition), 96, 251-264. [Google Scholar] [CrossRef] 
[41] Schmidt-Erfurth, U. and Hasan, T. (2000) Mechanisms of Action of Photodynamic Therapy with Verteporfin for the Treatment of Age-Related Macular Degeneration. Survey of Ophthalmology, 45, 195-214. [Google Scholar] [CrossRef] [PubMed]
[42] Chan, W. (2003) Choroidal Vascular Remodelling in Central Serous Chorioretinopathy after Indocyanine Green Guided Photodynamic Therapy with Verteporfin: A Novel Treatment at the Primary Disease Level. British Journal of Ophthalmology, 87, 1453-1458. [Google Scholar] [CrossRef] [PubMed]
[43] Uetani, R., Ito, Y., Oiwa, K., Ishikawa, K. and Terasaki, H. (2012) Half-dose vs One-Third-Dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy. Eye, 26, 640-649. [Google Scholar] [CrossRef] [PubMed]
[44] Lim, J.I., Glassman, A.R., Aiello, L.P., Chakravarthy, U., Flaxel, C.J. and Spaide, R.F. (2014) Collaborative Retrospective Macula Society Study of Photodynamic Therapy for Chronic Central Serous Chorioretinopathy. Ophthalmology, 121, 1073-1078. [Google Scholar] [CrossRef] [PubMed]
[45] Dorin, G. (2003) Subthreshold and Micropulse Diode Laser Photocoagulation. Seminars in Ophthalmology, 18, 147-153. [Google Scholar] [CrossRef] [PubMed]
[46] Roider, J. (1999) Laser Treatment of Retinal Diseases by Subthreshold Laser Effects. Seminars in Ophthalmology, 14, 19-26. [Google Scholar] [CrossRef] [PubMed]
[47] Roca, J.A., Wu, L., Fromow-Guerra, J., Rodríguez, F.J., Berrocal, M.H., Rojas, S., et al. (2018) Yellow (577 nm) Micropulse Laser versus Half-Dose Verteporfin Photodynamic Therapy in Eyes with Chronic Central Serous Chorioretinopathy: Results of the Pan-American Collaborative Retina Study (PACORES) Group. British Journal of Ophthalmology, 102, 1696-1700. [Google Scholar] [CrossRef] [PubMed]
[48] Iacono, P., Battaglia Parodi, M., Falcomatà, B. and Bandello, F. (2015) Central Serous Chorioretinopathy Treatments: A Mini Review. Ophthalmic Research, 55, 76-83. [Google Scholar] [CrossRef] [PubMed]
[49] Ezuddin, N.S., Lanza, N.L. and Weng, C.Y. (2016) Subthreshold Micropulse Laser Photocoagulation in the Management of Central Serous Chorioretinopathy. International Ophthalmology Clinics, 56, 165-174. [Google Scholar] [CrossRef] [PubMed]
[50] Khosla, P.K., Rana, S.S., Tewari, H.K., Azad, R.U. and Talwar, D. (1997) Evaluation of Visual Function Following Argon Laser Photocoagulation in Central Serous Retinopathy. Ophthalmic Surgery, Lasers and Imaging Retina, 28, 693-697. [Google Scholar] [CrossRef]